Short description
Iverson Genetic Diagnostics provides physicians with genetic diagnostic tools for disease detection and informed treatment purposes.
Description
Iverson Genetic Diagnostics provides diagnostic tools to prevent and treat chronic diseases for physicians. It develops genetic tests for disease detection and treatment. The company also provides a warfarin dosing panel that tests for variations in enzymes that can significantly affect warfarin response; and a high-risk HPV panel, a screening test that detects various HPVs. In addition, it offers an MTHFR assay that detects key variants in the metabolism of homocysteine that is associated with coronary artery disease, thrombosis, heart attacks, and strokes.
The company was founded in 2006 and is based in Bothell, Washington.
Total funding
$$43214321
Sign in for full access
Location
Charleston, South Carolina, United States, North America
Founded on
January 1, 2006
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Founders
Dean Sproles